Johnson & Johnson

Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.

Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.

Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.

More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.

Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company’s longstanding commitment to make lifesaving medicine available and accessible to those who need it most.

More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.

Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.